US FDA approves Regeneron’s ultra-rare blood disease drug
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare…
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health regulator approved its drug to treat a rare…
By Medha Singh (Reuters) -VinFast shares slumped for a third straight session on Friday, with the Vietnamese electric automaker now…
By Anirban Sen and Manya Saini (Reuters) – SoftBank Group Corp’s Arm Ltd is expected to report a revenue decline…
By Pete Schroeder WASHINGTON (Reuters) -Wall Street ended mixed Friday and U.S. Treasury yields stabilized after a recent surge and…
LOS ANGELES (Reuters) – Paul McCartney and Ringo Starr, the two living members of The Beatles, have reunited for a…
By Shariq Khan BENGALURU (Reuters) -Oil prices rose about 1% on Friday on signs of slowing U.S. output, but both…
By David Ljunggren OTTAWA (Reuters) -The Canadian government on Friday demanded that Meta lift a “reckless” ban on domestic news…
By Anirban Sen NEW YORK (Reuters) – SoftBank Group Corp has acquired the 25% stake in Arm Ltd it does…
By Bianca Flowers and Shivansh Tiwary (Reuters) -Deere & Co breezed past Wall Street estimates for third-quarter profit on Friday…
By Timothy Gardner WASHINGTON (Reuters) – The Biden administration has tightened controls on the export of materials and components for…